These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 12192139)

  • 21. Novel inhibitor of p38 MAP kinase as an anti-TNF-alpha drug: discovery of N-[4-[2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide (TAK-715) as a potent and orally active anti-rheumatoid arthritis agent.
    Miwatashi S; Arikawa Y; Kotani E; Miyamoto M; Naruo K; Kimura H; Tanaka T; Asahi S; Ohkawa S
    J Med Chem; 2005 Sep; 48(19):5966-79. PubMed ID: 16162000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and bioactivities of novel piperidylpyrimidine derivatives: inhibitors of tumor necrosis factor-alpha production.
    Fujiwara N; Fujita H; Iwai K; Kurimoto A; Murata S; Kawakami H
    Bioorg Med Chem Lett; 2000 Jun; 10(12):1317-20. PubMed ID: 10890155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of IL-15-stimulated TNF-alpha production by rolipram.
    Kasyapa CS; Stentz CL; Davey MP; Carr DW
    J Immunol; 1999 Sep; 163(5):2836-43. PubMed ID: 10453029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of proinflammatory macrophage responses and lymphocyte proliferation in vitro by ethyl acetate leaf extract from Daphne gnidium.
    Harizi H; Chaabane F; Ghedira K; Chekir-Ghedira L
    Cell Immunol; 2011; 267(2):94-101. PubMed ID: 21190680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Highly potent inhibitors of TNF-alpha production. Part I: discovery of new chemical leads and their structure-activity relationships.
    Matsui T; Kondo T; Nishita Y; Itadani S; Nakatani S; Omawari N; Sakai M; Nakazawa S; Ogata A; Mori H; Terai K; Kamoshima W; Ohno H; Obata T; Nakai H; Toda M
    Bioorg Med Chem; 2002 Dec; 10(12):3757-86. PubMed ID: 12413832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor necrosis factor-alpha production induced in T lymphocytes through the AIM/CD69 activation pathway.
    Santis AG; Campanero MR; Alonso JL; Tugores A; Alonso MA; Yagüe E; Pivel JP; Sánchez-Madrid F
    Eur J Immunol; 1992 May; 22(5):1253-9. PubMed ID: 1577066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FK506 potently inhibits T cell activation induced TNF-alpha and IL-1beta production in vitro by human peripheral blood mononuclear cells.
    Sakuma S; Kato Y; Nishigaki F; Sasakawa T; Magari K; Miyata S; Ohkubo Y; Goto T
    Br J Pharmacol; 2000 Aug; 130(7):1655-63. PubMed ID: 10928971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth-promoting activity of IL-1 alpha, IL-6, and tumor necrosis factor-alpha in combination with IL-2, IL-4, or IL-7 on murine thymocytes. Differential effects on CD4/CD8 subsets and on CD3+/CD3- double-negative thymocytes.
    Suda T; Murray R; Guidos C; Zlotnik A
    J Immunol; 1990 Apr; 144(8):3039-45. PubMed ID: 1969882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation.
    Sekut L; Yarnall D; Stimpson SA; Noel LS; Bateman-Fite R; Clark RL; Brackeen MF; Menius JA; Connolly KM
    Clin Exp Immunol; 1995 Apr; 100(1):126-32. PubMed ID: 7697910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of astragaloside IV on T, B lymphocyte proliferation and peritoneal macrophage function in mice.
    Wang YP; Li XY; Song CQ; Hu ZB
    Acta Pharmacol Sin; 2002 Mar; 23(3):263-6. PubMed ID: 11918853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mechanisms of production of tumor necrosis factor (TNF)--reconstitution experiment white nude mice].
    Watanabe N; Sone H; Neda H; Niitsu Y; Urushizaki I
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1284-9. PubMed ID: 6375575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune functions of tumor necrosis factor. I. Tumor necrosis factor induces apoptosis of mouse thymocytes and can also stimulate or inhibit IL-6-induced proliferation depending on the concentration of mitogenic costimulation.
    Hernández-Caselles T; Stutman O
    J Immunol; 1993 Oct; 151(8):3999-4012. PubMed ID: 8409382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovering novel 3-nitroquinolines as a new class of anticancer agents.
    Li HH; Huang H; Zhang XH; Luo XM; Lin LP; Jiang HL; Ding J; Chen KX; Liu H
    Acta Pharmacol Sin; 2008 Dec; 29(12):1529-38. PubMed ID: 19026174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor growth increases Ia- macrophage synthesis of tumor necrosis factor-alpha and prostaglandin E2: changes in macrophage suppressor activity.
    Alleva DG; Burger CJ; Elgert KD
    J Leukoc Biol; 1993 May; 53(5):550-8. PubMed ID: 8388910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2-aminothiazole as a novel kinase inhibitor template. Structure-activity relationship studies toward the discovery of N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1- piperazinyl)]-2-methyl-4-pyrimidinyl]amino)]-1,3-thiazole-5-carboxamide (dasatinib, BMS-354825) as a potent pan-Src kinase inhibitor.
    Das J; Chen P; Norris D; Padmanabha R; Lin J; Moquin RV; Shen Z; Cook LS; Doweyko AM; Pitt S; Pang S; Shen DR; Fang Q; de Fex HF; McIntyre KW; Shuster DJ; Gillooly KM; Behnia K; Schieven GL; Wityak J; Barrish JC
    J Med Chem; 2006 Nov; 49(23):6819-32. PubMed ID: 17154512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual role of anti-TNF therapy: enhancement of TCR-mediated T cell activation in peripheral blood and inhibition of inflammation in target tissues.
    Bosè F; Raeli L; Garutti C; Frigerio E; Cozzi A; Crimi M; Caprioli F; Scavelli R; Altomare G; Geginat J; Abrignani S; Reali E
    Clin Immunol; 2011 May; 139(2):164-76. PubMed ID: 21334981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Tissue specific lymphoid in vitro and in vivo cell proliferation inhibition with calves' spleen extract (lymphocyte chalone)].
    Heidemann E; Ganser H; Podgornik N; Rutsch H; Wilms K; Wörz F
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1115-9. PubMed ID: 148176
    [No Abstract]   [Full Text] [Related]  

  • 38. 4-Arylamino-6-nitroquinazolines: Synthesis and their activities against neglected disease leishmaniasis.
    Saad SM; Ghouri N; Perveen S; Khan KM; Choudhary MI
    Eur J Med Chem; 2016 Jan; 108():13-20. PubMed ID: 26619389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
    Alleva DG; Burger CJ; Elgert KD
    J Immunol; 1994 Aug; 153(4):1674-86. PubMed ID: 8046239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rho kinase promotes alloimmune responses by regulating the proliferation and structure of T cells.
    Tharaux PL; Bukoski RC; Rocha PN; Crowley SD; Ruiz P; Nataraj C; Howell DN; Kaibuchi K; Spurney RF; Coffman TM
    J Immunol; 2003 Jul; 171(1):96-105. PubMed ID: 12816987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.